Family 12: Genomic and Epigenetic Regulation

Family overview. The epigenome — DNA methylation, histone modifications, chromatin remodelling, non-coding RNAs — determines which genes are expressed in response to environmental signals without changing the DNA sequence. Epigenetic dysregulation can stably alter cellular programs in response to transient triggers, providing a molecular mechanism for how infection produces durable disease.

Concrete mechanisms and ME/CFS evidence:

Full discussion: Genetic and Epigenetic Factors.

Evidence status: Established (methylation findings in multiple independent cohorts); Preliminary (telomere — single study; needs replication).

References

Helliwell, Amber M., Peter A. Stockwell, Christina D. Edgar, Aniruddha Chatterjee, and Warren P. Tate. 2022. “Dynamic Epigenetic Changes During a Relapse and Recovery Cycle in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.” Epigenomics 14 (19): 1243–58. https://doi.org/10.2217/epi-2022-0212.
Rajeevan, Mangalathu S., Joseph Murray, Lisa P. Oakley, Jin-Mann S. Lin, and Elizabeth R. Unger. 2018. “Association of Chronic Fatigue Syndrome with Premature Telomere Attrition.” Journal of Translational Medicine 16 (1): 44. https://doi.org/10.1186/s12967-018-1414-x.
Roberts, Amanda D L, Simon Wessely, Trudie Chalder, Andrew Papadopoulos, and Anthony J Cleare. 2017. “Glucocorticoid Resistance in ME/CFS.” TBD.
Trivedi, Malav S., Elisa Oltra, Leonor Sarria, Angeles Martin-Martinez, Carlos Tornero, Rosa M. Escorihuela, José Alegre, Joan Dalmau, and Elisa Oltra. 2018. “Identification of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-Associated DNA Methylation Patterns.” PLOS ONE 13 (7): e0201066. https://doi.org/10.1371/journal.pone.0201066.